Unveiling the Germline Predisposition to Myeloproliferative Neoplasms

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

The classic Ph-negative myeloproliferative neoplasms (MPN) are a group of clonal hematopoietic disorders caused by a dysregulated JAK/STAT signal transduction because of acquired somatic mutations of JAK2, CALR or MPL genes. They are sporadic diseases but there are several lines of evidence that support the role of germline factors in the pathogenesis of MPN: the existence of familial clustering, the presence of more than one clone in some patients, the known existence of common polymorphisms that cause predisposition to MPN. In this study, we would like to define the germline predisposition to MPN.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• A diagnosis of PV, ET, prePMF, overt PMF or MPN-U according to 2016 WHO criteria

• Characterization of the MPN driver mutation performed at any moment before enrolment

• diagnosis of MPN made when the patient was younger than 27 years old OR at least a second case of hematologic malignancies in first or second-degree relatives

Locations
Other Locations
Italy
Fondazione IRCCS Policlinico San Matteo
RECRUITING
Pavia
Contact Information
Primary
Elisa Rumi
e.rumi@smatteo.pv.it
0382-503084
Time Frame
Start Date: 2022-06-27
Estimated Completion Date: 2030-12-31
Participants
Target number of participants: 313
Related Therapeutic Areas
Sponsors
Leads: Fondazione IRCCS Policlinico San Matteo di Pavia

This content was sourced from clinicaltrials.gov